Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Mol Cancer Ther. 2016 Nov 9;16(1):124–133. doi: 10.1158/1535-7163.MCT-16-0503

Figure 1.

Figure 1

A cartoon depicting the four basic steps of the pretargeted radioimmunotherapy approach used in these studies is shown (A). Also depicted is the reaction between the two components (TCO and Tz) on which the system is based (B) and the two 177Lu-labeled ligands used in these studies (C).